205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
13.14%
Revenue growth 1.25-1.5x MCHP's 11.09%. Bruce Berkowitz would examine if growth advantage is sustainable.
12.87%
Cost growth 1.25-1.5x MCHP's 9.63%. Martin Whitman would scrutinize competitive cost position.
13.66%
Gross profit growth 1.25-1.5x MCHP's 12.12%. Bruce Berkowitz would examine sustainability.
0.46%
Margin expansion below 50% of MCHP's 0.93%. Michael Burry would check for structural issues.
0.94%
R&D growth less than half of MCHP's 15.56%. David Dodd would verify if efficiency advantage is sustainable.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
11.71%
Operating expenses growth 1.1-1.25x MCHP's 10.56%. Bill Ackman would demand justification.
12.59%
Total costs growth 1.25-1.5x MCHP's 10.06%. Martin Whitman would scrutinize control.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
11.34%
Similar EBITDA growth to MCHP's 14.60%. Walter Schloss would investigate industry trends.
-1.59%
EBITDA margin decline while MCHP shows 3.16% growth. Joel Greenblatt would examine position.
17.15%
Operating income growth 1.25-1.5x MCHP's 14.56%. Bruce Berkowitz would examine sustainability.
3.55%
Operating margin growth 1.25-1.5x MCHP's 3.13%. Bruce Berkowitz would examine sustainability.
75.00%
Other expenses growth while MCHP reduces costs. John Neff would investigate differences.
17.82%
Pre-tax income growth 1.25-1.5x MCHP's 12.75%. Bruce Berkowitz would examine sustainability.
4.14%
Pre-tax margin growth exceeding 1.5x MCHP's 1.49%. David Dodd would verify competitive advantages.
11.86%
Similar tax expense growth to MCHP's 11.11%. Walter Schloss would investigate patterns.
20.87%
Net income growth exceeding 1.5x MCHP's 13.33%. David Dodd would verify competitive advantages.
6.83%
Net margin growth exceeding 1.5x MCHP's 2.02%. David Dodd would verify competitive advantages.
20.00%
EPS change of 20.00% while MCHP is flat. Bruce Berkowitz would examine quality.
20.00%
Diluted EPS change of 20.00% while MCHP is flat. Bruce Berkowitz would examine quality.
0.82%
Share count reduction exceeding 1.5x MCHP's 13.33%. David Dodd would verify capital allocation.
1.33%
Diluted share reduction exceeding 1.5x MCHP's 13.33%. David Dodd would verify capital allocation.